Apomorphine and levodopa challenge in patients with a focal midbrain lesion

Mov Disord. 1999 Mar;14(2):269-75. doi: 10.1002/1531-8257(199903)14:2<269::aid-mds1012>3.0.co;2-x.

Abstract

Three patients who presented with parkinsonian signs resulting from a focal midbrain lesion are reported. In all patients parkinsonian features occurred acutely and improved following acute challenge with apomorphine but not with levodopa. Remission of parkinsonian signs occurred spontaneously to a different degree. Inconsistent clinical response following administration of levodopa has been well documented in patients with focal midbrain lesions associated with parkinsonian signs; however, the efficacy of apomorphine has not been tested before. Anatomic or etiologic features do not allow us to predict in which cases parkinsonian signs secondary to a midbrain lesion would respond to levodopa or to dopamine agonists. A trial with apomorphine is warranted in all such cases.

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / therapeutic use*
  • Apomorphine / administration & dosage
  • Apomorphine / therapeutic use*
  • Brain Damage, Chronic* / complications
  • Brain Damage, Chronic* / drug therapy
  • Female
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use*
  • Male
  • Mesencephalon / injuries*
  • Mesencephalon / pathology
  • Middle Aged
  • Parkinson Disease, Secondary* / drug therapy
  • Parkinson Disease, Secondary* / etiology
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Levodopa
  • Apomorphine